Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview

Plant Phenolics: Extraction, Analysis and Their Antioxidant and Anticancer Properties

Dai, J., & Mumper, R. J. (2010) · Molecules · doi:10.3390/molecules15107313 · Cited by 4,541 · see citing works

Neuropathological alterations in Alzheimer disease

Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345 · see citing works

The chemical diversity and distribution of glucosinolates and isothiocyanates among plants

Fahey, J. W., Zalcmann, A. T., & Talalay, P. (2001) · Phytochemistry · doi:10.1016/s0031-9422(00)00316-2 · Cited by 2,968 · see citing works

Chemistry and biochemistry of dietary polyphenols

Tsao, R. (2010) · Nutrients · doi:10.3390/nu2121231 · Cited by 2,415 · see citing works

Function and regulation of CREB family transcription factors in the nervous system

Lonze, B. E., & Ginty, D. D. (2002) · Neuron · doi:10.1016/s0896-6273(02)00828-0 · Cited by 2,127 · see citing works

The Pathobiology of Vascular Dementia

Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857 · see citing works

Curcumin: From ancient medicine to current clinical trials

Hatcher, H., Planalp, R. P., Cho, J., Torti, F. M., & Torti, S. V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7452-4 · Cited by 1,847 · see citing works

Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

(1998) · Europe PMC (PubMed Central) · Cited by 1,594 · see citing works

The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse

Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08370.2001 · Cited by 1,530 · see citing works

Vascular dementia

O'Brien, J. T., & Thomas, A. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00463-8 · Cited by 1,136 · see citing works

Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

Nagahara, A. H., Merrill, D. A., Coppola, G., Tsukada, S., Schroeder, B. E., Shaked, G. M., Wang, L., Blesch, A., Kim, A., Conner, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1912 · Cited by 1,034 · see citing works

Cellular Defenses against Unfolded Proteins

Sherman, M. Y., & Goldberg, A. L. (2001) · Neuron · doi:10.1016/s0896-6273(01)00177-5 · Cited by 984 · see citing works

Tea polyphenols: prevention of cancer and optimizing health

Mukhtar, H., & Ahmad, N. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.6.1698s · Cited by 904 · see citing works

Efficacy of berberine in patients with type 2 diabetes mellitus

Yin, J., Xing, H., & Ye, J. (2008) · Metabolism · doi:10.1016/j.metabol.2008.01.013 · Cited by 801 · see citing works

Association of coffee and caffeine intake with the risk of Parkinson disease

Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778 · see citing works

Prospective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women

Ascherio, A., Zhang, S. M., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001) · Annals of Neurology · doi:10.1002/ana.1052 · Cited by 677 · see citing works

Curcumin labels amyloid pathology in vivo , disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model

Garcı́a-Alloza, M., Borrelli, L. A., Rozkalne, A., Hyman, B. T., & Bacskai, B. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04613.x · Cited by 663 · see citing works

Clinical trials and late‐stage drug development for <scp>A</scp>lzheimer's disease: an appraisal from 1984 to 2014

Schneider, L. S., Mangialasche, F., Andreasen, N., Feldman, H., Giacobini, E., Jones, R., Mantua, V., Mecocci, P., Pani, L., Winblad, B., et al. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12191 · Cited by 651 · see citing works

AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-β Peptide Metabolism

Vingtdeux, V., Giliberto, L., Zhao, H., Chandakkar, P., Wu, Q., Simon, J. E., Janle, E. M., Lobo, J., Ferruzzi, M. G., Davies, P. J., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.060061 · Cited by 648 · see citing works

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial

Wilcock, G. K., Lilienfeld, S., & Gaens, E. (2000) · BMJ · doi:10.1136/bmj.321.7274.1445 · Cited by 623 · see citing works

A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol

Russo, E. B., & Guy, G. W. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.08.026 · Cited by 608 · see citing works

Glucosinolates and isothiocyanates in health and disease

Dinkova‐Kostova, A. T., & Kostov, R. V. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.04.003 · Cited by 607 · see citing works

Six-Month Randomized, Placebo-Controlled, Double-Blind, Pilot Clinical Trial of Curcumin in Patients With Alzheimer Disease

Baum, L., Lam, C. W. K., Cheung, S. K. K., Kwok, T. C. Y., Lui, V. W.-C., Tsoh, J., LAM, L. C. W., Leung, V., Hui, E., Ng, C., et al. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318160862c · Cited by 594 · see citing works

Galanthamine from snowdrop?the development of a modern drug against Alzheimer?s disease from local Caucasian knowledge

Heinrich, M., & Teoh, H. L. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.02.012 · Cited by 587 · see citing works

Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease

Barage, S. H., & Sonawane, K. D. (2015) · Neuropeptides · doi:10.1016/j.npep.2015.06.008 · Cited by 579 · see citing works

Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial

Husebo, B. S., Ballard, C., Sandvik, R., Nilsen, O. B., & Aarsland, D. (2011) · BMJ · doi:10.1136/bmj.d4065 · Cited by 571 · see citing works

The neuroprotective potential of flavonoids: a multiplicity of effects

Vauzour, D., Vafeiadou, K., Rodriguez‐Mateos, A., Rendeiro, C., & Spencer, J. P. E. (2008) · Genes & Nutrition · doi:10.1007/s12263-008-0091-4 · Cited by 561 · see citing works

Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

Ringman, J. M., Frautschy, S. A., Teng, E., Begum, A. N., Bardens, J., Beigi, M., Gylys, K. H., Badmaev, V., Heath, D. D., Apostolova, L. G., et al. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt146 · Cited by 546 · see citing works

Rivastigmine for Alzheimer’s disease.

Birks, J. S., Chong, L.-Y., & Grimley Evans, J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001191.pub4 · Cited by 534 · see citing works

Resveratrol protects against global cerebral ischemic injury in gerbils

Wang, Q., Xu, J., Rottinghaus, G. E., Simonyi, Á., Lubahn, D. E., Sun, G. Y., & Sun, A. Y. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03543-6 · Cited by 528 · see citing works

Neuroprotective effects of curcumin

Cole, G. M., Teter, B., & Frautschy, S. A. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_8 · Cited by 516 · see citing works

Polyphenols and cardiovascular disease: effects on endothelial and platelet function

Vita, J. A. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.292s · Cited by 495 · see citing works

Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG

Na, H., & Surh, Y. (2007) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.10.006 · Cited by 486 · see citing works

Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer’s disease animal models

Baum, L., & Ng, A. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6403 · Cited by 483 · see citing works

The neuropathology and cerebrovascular mechanisms of dementia

Raz, L., Knoefel, J. E., & Bhaskar, K. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.164 · Cited by 470 · see citing works

Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine1

WANG, R., YAN, H., & TANG, X.-C. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00255.x · Cited by 470 · see citing works

Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain β-amyloid production

Arendash, G. W., Schleif, W. S., Rezai-Zadeh, K. P., Jackson, E. K., Zacharia, L. C., Cracchiolo, J. R., Shippy, D. C., & Tan, J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.07.021 · Cited by 459 · see citing works

Health Benefits of Moringa oleifera

Razis, A. F. A., Ibrahim, M. D., & Kntayya, S. B. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.20.8571 · Cited by 452 · see citing works

Profiling Glucosinolates and Phenolics in Vegetative and Reproductive Tissues of the Multi-Purpose Trees Moringa oleifera L. (Horseradish Tree) and Moringa stenopetala L.

Bennett, R. N., Mellon, F. A., Foidl, N., Pratt, J. H., DuPont, M. S., Perkins, L., & Kroon, P. A. (2003) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0211480 · Cited by 445 · see citing works

New Acetylcholinesterase Inhibitors for Alzheimer's Disease

Mehta, M., Adem, A., & Sabbagh, M. N. (2011) · International Journal of Alzheimer s Disease · doi:10.1155/2012/728983 · Cited by 436 · see citing works

Hepatotoxicity of high oral dose (−)-epigallocatechin-3-gallate in mice

Lambert, J. D., Kennett, M. J., Sang, S., Reuhl, K. R., Ju, J., & Yang, C. S. (2009) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.10.030 · Cited by 436 · see citing works

Midlife Coffee and Tea Drinking and the Risk of Late-Life Dementia: A Population-Based CAIDE Study

Eskelinen, M. H., Ngandu, T., Tuomilehto, J., Soininen, H., & Kivipelto, M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0920 · Cited by 428 · see citing works

Hepatotoxicity from green tea: a review of the literature and two unpublished cases

Mazzanti, G., Menniti‐Ippolito, F., Moro, P. A., Cassetti, F., Raschetti, R., Santuccio, C., & Mastrangelo, S. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0610-7 · Cited by 412 · see citing works

Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement

Esposito, G., Scuderi, C., Valenza, M., Togna, G. I., Latina, V., De Filippis, D., Cipriano, M., Carratù, M. R., Iuvone, T., & Steardo, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028668 · Cited by 410 · see citing works

Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer’s Disease

Martín-Moreno, A. M., Reigada, D., Ramírez, B. G., Mechoulam, R., Innamorato, N. G., Cuadrado, A., & CEBALLOS, M. L. D. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.071290 · Cited by 402 · see citing works

Protective effect of resveratrol on β-amyloid-induced oxidative PC12 cell death

Jang, J.-H. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00062-5 · Cited by 391 · see citing works

A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species

Küpeli̇, E., Koşar, M., Yeşilada, E., & Başer, K. H. C. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02200-2 · Cited by 379 · see citing works

Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders

Kulkarni, S. K., & Dhir, A. (2009) · Phytotherapy Research · doi:10.1002/ptr.2968 · Cited by 367 · see citing works

Neuroprotective effect of cannabidiol, a non‐psychoactive component from<i>Cannabis sativa</i>, on β‐amyloid‐induced toxicity in PC12 cells

Iuvone, T., Esposito, G., Esposito, R., Santamaria, R., Di Rosa, M., & Izzo, A. A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2003.02327.x · Cited by 361 · see citing works

Does caffeine intake protect from Alzheimer's disease?

Maia, L., & de Mendonça, A. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.00421.x · Cited by 357 · see citing works

Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology

O'Brien, J. T., Holmes, C., Jones, M. S., Jones, R. W., Livingston, G., McKeith, I. G., Mittler, P. J., Passmore, P., Ritchie, C. W., Robinson, L. A., et al. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881116680924 · Cited by 355 · see citing works

Naturally occurring phytochemicals for the prevention of Alzheimer’s disease

Kim, J., Lee, H. J., & Lee, K. W. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06562.x · Cited by 354 · see citing works

The neuroprotective effects of caffeine: A prospective population study (the Three City Study)

Ritchie, K., Carrière, I., de Mendonça, A., Portet, F., Dartigues, J. F., Rouaud, O., Barberger-Gateau, P., & Ancelin, M. L. (2007) · Neurology · doi:10.1212/01.wnl.0000266670.35219.0c · Cited by 347 · see citing works

Disposition of Glucosinolates and Sulforaphane in Humans After Ingestion of Steamed and Fresh Broccoli

Conaway, C. C., Getahun, S. M., Liebes, L. L., et al. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc382_5 · Cited by 347 · see citing works

Role of mTOR in physiology and pathology of the nervous system

Swiech, L., Perycz, M., Malik, A., & Jaworski, J. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.08.015 · Cited by 338 · see citing works

Apolipoprotein E Polymorphism and Alzheimer Disease

Ganguli, M., Chandra, V., Kamboh, M. I., Johnston, J. M., Dodge, H. H., Thelma, B. K., Juyal, R. C., Pandav, R. S., Belle, S. H., & DeKosky, S. T. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.824 · Cited by 337 · see citing works

Pharmacological Targeting of the Transcription Factor Nrf2 at the Basal Ganglia Provides Disease Modifying Therapy for Experimental Parkinsonism

Jaźwa, A., Rojo, A. I., Innamorato, N. G., Hesse, M., Fernández‐Ruíz, J., & Cuadrado, A. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3731 · Cited by 329 · see citing works

Reactivity and Stability of Glucosinolates and Their Breakdown Products in Foods

Hanschen, F. S., Lamy, E., Schreiner, M., & Rohn, S. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201402639 · Cited by 317 · see citing works

Nicotinic receptor stimulation protects neurons against β‐amyloid toxicity

Kihara, T., Shimohama, S., Sawada, H., Kimura, J., Kume, T., Kochiyama, H., Maeda, T., & Akaike, A. (1997) · Annals of Neurology · doi:10.1002/ana.410420205 · Cited by 315 · see citing works

Vascular risk factors, cognitve decline, and dementia

Hanon, O. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s1839 · Cited by 314 · see citing works

Effect of storage, processing and cooking on glucosinolate content of Brassica vegetables

Song, L., & Thornalley, P. J. (2006) · Food and Chemical Toxicology · doi:10.1016/j.fct.2006.07.021 · Cited by 314 · see citing works

Cannabidiol <i>in vivo</i> blunts β‐amyloid induced neuroinflammation by suppressing IL‐1β and iNOS expression

Esposito, G., Scuderi, C., Savani, C., Steardo, L., De Filippis, D., Cottone, P., Iuvone, T., Cuomo, V, & Steardo, L. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707337 · Cited by 308 · see citing works

Caffeine Reverses Cognitive Impairment and Decreases Brain Amyloid-β Levels in Aged Alzheimer's Disease Mice

Arendash, G. W., Mori, T., Cao, C., Mamcarz, M., Runfeldt, M., Dickson, A., Rezai-Zadeh, K., Tan, J., Citron, B. A., Lin, X., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1087 · Cited by 308 · see citing works

Nicotinic Acetylcholine Receptor Signalling: Roles in Alzheimer’s Disease and Amyloid Neuroprotection

Buckingham, S. D., Jones, A. K., Brown, L. A., & Sattelle, D. B. (2009) · Pharmacological Reviews · doi:10.1124/pr.108.000562 · Cited by 307 · see citing works

Neuroprotective effects of resveratrol against β‐amyloid‐induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C

Han, Y.-S., Zheng, W., Bastianetto, S., Chabot, J., & Quirion, R. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705688 · Cited by 300 · see citing works

Huperzine A from Huperzia species—An ethnopharmacolgical review

Ma, R., Tan, C., Zhu, D., Gang, D. R., & Xiao, P. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2007.05.030 · Cited by 292 · see citing works

Sulforaphane as a Potential Protective Phytochemical against Neurodegenerative Diseases

Tarozzi, A., Angeloni, C., Malaguti, M., Morroni, F., Hrelia, S., & Hrelia, P. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/415078 · Cited by 286 · see citing works

PPARγ Agonists as Therapeutics for the Treatment of Alzheimer's Disease

Landreth, G. E., Jiang, Q., Mandrekar, S., & Heneka, M. T. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.003 · Cited by 277 · see citing works

Effects of natural antioxidants in neurodegenerative disease

Albarracín, S. L., Stab, B., Casas, Z., Sutachan, J. J., Samudio, I. J., González, J., Gonzalo, L., Capani, F., Morales, L., & Barreto, G. E. (2012) · Nutritional Neuroscience · doi:10.1179/1476830511y.0000000028 · Cited by 273 · see citing works

Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model

Durairajan, S. S. K., Liu, L.-F., Lu, J.-H., Chen, L.-L., Yuan, Q., Chung, S. K., Huang, L., Li, X.-S., Huang, J.-D., & Li, M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.02.016 · Cited by 271 · see citing works

Green Tea (-)-Epigallocatechin-3-Gallate Inhibits β-Amyloid-Induced Cognitive Dysfunction through Modification of Secretase Activity via Inhibition of ERK and NF-κB Pathways in Mice ,

Lee, J. W., Lee, Y. K., Ban, J. O., Ha, T. Y., Yun, Y. P., Han, S., Oh, K. W., & Hong, J. T. (2009) · Journal of Nutrition · doi:10.3945/jn.109.109785 · Cited by 269 · see citing works

Chemical and Structural Features Influencing the Biological Activity of Curcumin

Priyadarsini, K. I. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213805289228 · Cited by 265 · see citing works

Dietary resveratrol prevents Alzheimer’s markers and increases life span in SAMP8

Porquet, D., Casadesús, G., Bayod, S., Vicente, A., Canudas, A. M., Vilaplana, J., Pelegrı́, C., Sanfeliu, C., Camins, A., Pallàs, M., et al. (2012) · AGE · doi:10.1007/s11357-012-9489-4 · Cited by 264 · see citing works

Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis

Stinton, C., McKeith, I., Taylor, J.-P., Lafortune, L., Mioshi, E., Mak, E., Cambridge, V., Mason, J., Thomas, A., & O’Brien, J. T. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14121582 · Cited by 264 · see citing works

Cancer pain management according to WHO analgesic guidelines

Schug, S. A., Zech, D. F. J., & Dörr, U. (1990) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(05)80006-5 · Cited by 261 · see citing works

The marijuana component cannabidiol inhibits β-amyloid-induced tau protein hyperphosphorylation through Wnt/β-catenin pathway rescue in PC12 cells

Esposito, G., Filippis, D. D., Carnuccio, R., Izzo, A. A., & Iuvone, T. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0025-1 · Cited by 252 · see citing works

Translational Control via the Mammalian Target of Rapamycin Pathway Is Critical for the Formation and Stability of Long-Term Fear Memory in Amygdala Neurons

Parsons, R. G., Gafford, G. M., & Helmstetter, F. J. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4209-06.2006 · Cited by 251 · see citing works

Rivastigmine for Alzheimer's disease

Birks, J., & Evans, J. G. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001191.pub3 · Cited by 247 · see citing works

Neuroprotective effects of resveratrol in Alzheimer disease pathology

Rege, S. D., Geetha, T., Griffin, G. D., Broderick, T. L., & Babu, J. R. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00218 · Cited by 243 · see citing works

Huperzine A for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Yang, G., Wang, Y., Tian, J., & Liu, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074916 · Cited by 242 · see citing works

Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study

Vaney, C., Heinzel-Gutenbrunner, M., Jobin, P., Tschopp, F., Gattlen, B., Hagen, U., Schnelle, M., & Reif, M. (2004) · Multiple Sclerosis · doi:10.1191/1352458504ms1048oa · Cited by 239 · see citing works

Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane

Fimognari, C. (2002) · Carcinogenesis · doi:10.1093/carcin/23.4.581 · Cited by 237 · see citing works

Downregulation of PI3K/Akt/mTOR signaling pathway in curcumin-induced autophagy in APP/PS1 double transgenic mice

Wang, C., Zhang, X., Teng, Z., Zhang, T., & Li, Y. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.06.051 · Cited by 233 · see citing works

Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease

Yan, H., Xia, M., Wang, Y., Chang, X., Yao, X., Rao, S., Zeng, M., Tu, Y., Feng, R., Jia, W., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134172 · Cited by 233 · see citing works

Resveratrol, A Neuroprotective Supplement for Alzheimer's Disease

Li, F., Gong, Q., Dong, H., & Shi, J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212798919075 · Cited by 231 · see citing works

Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in β-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-κB involvement

Esposito, G., De Filippis, D., Maiuri, M. C., De Stefano, D., Carnuccio, R., & Iuvone, T. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.01.047 · Cited by 225 · see citing works

Cannabidiol Prevents Cerebral Infarction Via a Serotonergic 5-Hydroxytryptamine 1A Receptor–Dependent Mechanism

Mishima, K., Hayakawa, K., Abe, K., Ikeda, T., Egashira, N., Iwasaki, K., & Fujiwara, M. (2005) · Stroke · doi:10.1161/01.str.0000163083.59201.34 · Cited by 225 · see citing works

Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease

Konrath, E. L., Passos, C. D. S., Klein‐Júnior, L. C., & Henriques, A. T. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12090 · Cited by 219 · see citing works

Nicotine treatment of mild cognitive impairment

NEWHOUSE, P. A., Kellar, K. J., Aisen, P. S. S., White, H., Wesnes, K. A., Coderre, E. L., Pfaff, A., Wilkins, H., Howard, D., & Levin, E. D. (2012) · Neurology · doi:10.1212/wnl.0b013e31823efcbb · Cited by 218 · see citing works

Galantamine in Frontotemporal Dementia and Primary Progressive Aphasia

Kertesz, A., Morlog, D., Light, M., Blair, M., Davidson, W., Jesso, S., & Brashear, R. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000113034 · Cited by 217 · see citing works

Effect of Resveratrol on Antioxidant Enzyme Activities in the Brain of Healthy Rat

Mokni, M., Elkahoui, S., Limam, F., Amri, M., & Aouani, E. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9255-z · Cited by 213 · see citing works

Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease

Oddo, S., Caccamo, A., Green, K. N., Liang, K., Tran, L., Chen, Y., Leslie, F. M., & LaFerla, F. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408500102 · Cited by 211 · see citing works

Curcumin Protected PC12 Cells against Beta-Amyloid-Induced Toxicity through the Inhibition of Oxidative Damage and Tau Hyperphosphorylation

Park, S.-Y., Kim, H.-S., Cho, E.-K., Kwon, B.-Y., Phark, S., Hwang, K.-W., & Sul, D. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2008.05.030 · Cited by 209 · see citing works

Nicotinic receptors in aging and dementia

Picciotto, M. R., & Zoli, M. (2002) · Journal of Neurobiology · doi:10.1002/neu.10102 · Cited by 208 · see citing works

Neuroprotective Antioxidants from Marijuana a

Hampson, A. J., GRIMALDI, M., Miljkovic-Lolic, M., Wink, D. A., Rosenthal, R., & Axelrod, J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06193.x · Cited by 203 · see citing works

Vascular action of polyphenols

GHOSH, D. K., & Scheepens, A. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800182 · Cited by 194 · see citing works

Roles of AMP-activated Protein Kinase in Alzheimer’s Disease

Cai, Z., Yan, L., Li, K., Quazi, S. H., & Zhao, B. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8173-2 · Cited by 191 · see citing works

Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia

Walther, S., Mahlberg, R., Eichmann, U., & Kunz, D. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0343-1 · Cited by 190 · see citing works

Galantamine treatment of vascular dementia: A randomized trial

Auchus, A. P., Brashear, H. R., Salloway, S., Korczyn, A. D., De Deyn, P. P., & Gassmann-Mayer, C. (2007) · Neurology · doi:10.1212/01.wnl.0000266625.31615.f6 · Cited by 189 · see citing works

Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology.

Laurent, C., Eddarkaoui, S., Derisbourg, M. J., Leboucher, A., Demeyer, D., Carrier, S., Schneider, M., Hamdane, M., Müller, C., Buée, L., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.027 · Cited by 189 · see citing works

Green Tea Epigallocatechin-3-Gallate (EGCG) and Other Flavonoids Reduce Alzheimer's Amyloid-Induced Mitochondrial Dysfunction

Dragicevic, N., Smith, A., Lin, X., Yuan, F., Copes, N., Delic, V., Tan, J., Cao, C., Shytle, R. D., & Bradshaw, P. C. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101629 · Cited by 189 · see citing works

Caffeine and risk of Parkinson’s disease in a large cohort of men and women

Palacios, N., Gao, X., McCullough, M. L., Schwarzschild, M. A., Shah, R., Gapstur, S., & Ascherio, A. (2012) · Movement Disorders · doi:10.1002/mds.25076 · Cited by 185 · see citing works

Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model

Molchan, S. E., Martínez, R. A., Hill, J., Weingartner, H. J., Thompson, K., Vitiello, B., & Sunderland, T. (1992) · Brain Research Reviews · doi:10.1016/0165-0173(92)90017-g · Cited by 184 · see citing works

Berberine alters the processing of Alzheimer’s amyloid precursor protein to decrease Aβ secretion

Asai, M., Iwata, N., Yoshikawa, A., Aizaki, Y., Ishiura, S., Saido, T. C., & Maruyama, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.11.043 · Cited by 182 · see citing works

Clinical development of curcumin in neurodegenerative disease

Hu, S., Maiti, P., Ma, Q., Zuo, X., Jones, M. R., Cole, G. M., & Frautschy, S. A. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1044981 · Cited by 179 · see citing works

Neuroprotective Role of Trans-Resveratrol in a Murine Model of Familial Alzheimer's Disease

Porquet, D., Griñán‐Ferré, C., Ferrer, I., Camins, A., Sanfeliu, C., del Valle, J., & Pallàs, M. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140444 · Cited by 178 · see citing works

Green tea (−)epigallocatechin-3-gallate reverses oxidative stress and reduces acetylcholinesterase activity in a streptozotocin-induced model of dementia

Biasibetti, R., Tramontina, A. C., Costa, A. P., Dutra, M. F., Quincozes‐Santos, A., Nardin, P., Bernardi, C. L., Wartchow, K. M., Lunardi, P. S., & Gonçalves, C. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.08.039 · Cited by 177 · see citing works

Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB1 receptors

Wagner, J. A., Járai, Z., Bátkai, S., & Kunos, G. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01112-8 · Cited by 177 · see citing works

The Response of Agitated Behavior to Pain Management in Persons with Dementia

Husebo, B. S., Ballard, C. G., Cohen‐Mansfield, J., Seifert, R., & Aarsland, D. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.12.006 · Cited by 171 · see citing works

Antiradical and antioxidant activities of alkaloids isolated from Mahonia aquifolium. Structural aspects

Račková, L., Májeková, M., Košťálová, D., et al. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.06.035 · Cited by 168 · see citing works

Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology

O'Brien, J. T., & Burns, A. S. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110387547 · Cited by 163 · see citing works

Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5Y<i>^APP+</i> Cells Through PPARγ Involvement

Scuderi, C., Steardo, L., & Esposito, G. (2014) · Phytotherapy Research · doi:10.1002/ptr.5095 · Cited by 161 · see citing works

Caffeine protects against oxidative stress and Alzheimer's disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet

Prasanthi, J. R. P., Dasari, B., Marwarha, G., Larson, T., Chen, X., Geiger, J. D., & Ghribi, O. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.07.007 · Cited by 159 · see citing works

Cannabis-based medicine reduces multiple pathological processes in AβPP/PS1 mice

Aso, E., Sánchez-Pla, A., Vegas-Lozano, E., Maldonado, R., & Ferrer, I. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141014 · Cited by 154 · see citing works

Huperzine A attenuates amyloid β‐peptide fragment 25‐35‐induced apoptosis in rat cortical neurons via inhibiting reactive oxygen species formation and caspase‐3 activation

Xiao, X., Zhang, H., & Tang, X. C. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.10075 · Cited by 153 · see citing works

Curcumin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-stimulated BV2 microglia

Jin, C., Lee, J.-D., Park, C., Choi, Y. H., & Kim, G. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00651.x · Cited by 152 · see citing works

Kinetic difference of berberine between hippocampus and plasma in rat after intravenous administration of Coptidis rhizoma extract

Wang, X., Wang, R., Xing, D., et al. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.02.033 · Cited by 148 · see citing works

Neuroprotective Properties of Curcumin in Alzheimer’s Disease – Merits and Limitations

Chin, D., Huebbe, P., Pallauf, K., & Rimbach, G. H. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990210 · Cited by 147 · see citing works

Role of increased expression of the proteasome in the protective effects of sulforaphane against hydrogen peroxide-mediated cytotoxicity in murine neuroblastoma cells

Kwak, M.-K., Cho, J.-M., Huang, B., Shin, S., & Kensler, T. W. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.029 · Cited by 143 · see citing works

Sulforaphane Activates Heat Shock Response and Enhances Proteasome Activity through Up-regulation of Hsp27

Gan, N., Wu, Y.-C., Brunet, M., Garrido, C., Chung, F., Dai, C., & Mi, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.152686 · Cited by 142 · see citing works

Alzheimer's disease: early diagnosis and treatment.

Chu, L. (2012) · PubMed · Cited by 141 · see citing works

Modulating gut microbiota as an anti-diabetic mechanism of berberine

Han, J.-L., Lin, H., & Huang, W. (2011) · Medical Science Monitor · doi:10.12659/msm.881842 · Cited by 140 · see citing works

Berberine suppresses amyloid-beta-induced inflammatory response in microglia by inhibiting nuclear factor-kappaB and mitogen-activated protein kinase signalling pathways

Jia, L., Liu, J., Song, Z., Pan, X., Chen, L., Cui, X. K., & Wang, Μ. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01529.x · Cited by 136 · see citing works

Effect of flavonoids on learning, memory and neurocognitive performance: relevance and potential implications for Alzheimer's disease pathophysiology

Vauzour, D. (2013) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.6473 · Cited by 136 · see citing works

Galantamine for vascular cognitive impairment

Birks, J., & Craig, D. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004746.pub2 · Cited by 135 · see citing works

Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer’s disease: a review

Kurz, A., Farlow, M. R., & Lefèvre, G. Y. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02052.x · Cited by 134 · see citing works

High Blood Caffeine Levels in MCI Linked to Lack of Progression to Dementia

Cao, C., Loewenstein, D., Lin, X., Zhang, C., Wang, L., Duara, R., Wu, Y., Giannini, A., Bai, G., Cai, J., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111781 · Cited by 133 · see citing works

Coffee Intake in Midlife and Risk of Dementia and its Neuropathologic Correlates

Gelber, R. P., Petrovitch, H., Masaki, K. H., Ross, G. W., & White, L. R. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101428 · Cited by 133 · see citing works

Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by β-amyloid protein-(1–40) in rat

Wang, R., Zhang, H., & Tang, X. C. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01030-5 · Cited by 131 · see citing works

<i>Moringa oleifera</i>Mitigates Memory Impairment and Neurodegeneration in Animal Model of Age-Related Dementia

Sutalangka, C., Wattanathorn, J., Muchimapura, S., & Thukham-mee, W. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/695936 · Cited by 131 · see citing works

The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer’s Disease

Deardorff, W. J., Feen, E. S., & Grossberg, G. T. (2015) · Drugs & Aging · doi:10.1007/s40266-015-0273-x · Cited by 129 · see citing works

Epigallocatechin gallate attenuates amyloid β-induced inflammation and neurotoxicity in EOC 13.31 microglia

Wei, J. C., Huang, H., Chen, W. J., Huang, C., Peng, C., & Lin, C. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.048 · Cited by 128 · see citing works

A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea‐Predominant Irritable Bowel Syndrome

Chen, C., Tao, C., Liu, Z., Lü, M., Pan, Q., Zheng, L., Li, Q., Song, Z., & Fichna, J. (2015) · Phytotherapy Research · doi:10.1002/ptr.5475 · Cited by 127 · see citing works

Sulforaphane suppresses LPS-induced inflammation in primary rat microglia

Brandenburg, L., Kipp, M., Lucius, R., Pufe, T., & Wruck, C. J. (2009) · Inflammation Research · doi:10.1007/s00011-009-0116-5 · Cited by 126 · see citing works

An overview on neuroprotective effects of isothiocyanates for the treatment of neurodegenerative diseases

Giacoppo, S., Galuppo, M., Montaut, S., Iori, R., Rollin, P., Bramanti, P., & Mazzon, E. (2015) · Fitoterapia · doi:10.1016/j.fitote.2015.08.001 · Cited by 123 · see citing works

Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease

Srivareerat, M., Tran, T. T., Salim, S., Aleisa, A. M., & Alkadhi, K. A. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.015 · Cited by 121 · see citing works

In vitro antiplasmodial activity of antimalarial medicinal plants used in Vietnamese traditional medicine

Tran, Q. L., Tezuka, Y., Ueda, J., et al. (2003) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(03)00045-x · Cited by 118 · see citing works

(−)-Epigallocatechin-3-Gallate Ameliorates Learning and Memory Deficits by Adjusting the Balance of TrkA/p75NTR Signaling in APP/PS1 Transgenic Mice

Liu, M., Chen, F., Sha, L., Wang, S., Lin, T., Yao, L., He, M., Yao, Z., Liu, H., Zhu, Z., et al. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8608-2 · Cited by 117 · see citing works

Huperzine A in the Treatment of Alzheimer′s Disease and Vascular Dementia: A Meta‐Analysis

Xing, S.-H., Zhu, C., Zhang, R., & An, L. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/363985 · Cited by 117 · see citing works

Nicotine breaks down preformed Alzheimer’s β-amyloid fibrils in vitro

Ono, K., Hasegawa, K., Yamada, M., & Naiki, H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01417-8 · Cited by 116 · see citing works

Epigallocatechin-3-gallate suppresses NF-κB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells

Kim, S.-J., Jeong, H.-J., Lee, K.-M., Myung, N.-Y., An, N.-H., Mo Yang, W., Kyu Park, S., Lee, H.-J., Hong, S.-H., Kim, H.-M., et al. (2007) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.11.001 · Cited by 116 · cited 2× · see citing works

Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment

White, H. K., & Levin, E. D. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1614-8 · Cited by 116 · see citing works

Effects of turmeric on Alzheimer′s disease with behavioral and psychological symptoms of dementia

Hishikawa, N., Takahashi, Y., Amakusa, Y., Tanno, Y., Tuji, Y., Niwa, H., Murakami, N., & Krishna, U. (2012) · AYU (An International Quarterly Journal of Research in Ayurveda) · doi:10.4103/0974-8520.110524 · Cited by 115 · see citing works

Chemical and Structural Features Influencing the Biological Activity of Curcumin

Priyadarsini, K. I. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319110010 · Cited by 115 · see citing works

Molecular and Cellular Mechanism of Okadaic Acid (OKA)-Induced Neurotoxicity: A Novel Tool for Alzheimer’s Disease Therapeutic Application

Kamat, P. K., Rai, S., Swarnkar, S., Shukla, R., & Nath, C. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8699-4 · Cited by 112 · see citing works

Pleiotropic Protective Effects of Phytochemicals in Alzheimer's Disease

Davinelli, S., Sapere, N., Zella, D., Bracale, R., Intrieri, M., & Scapagnini, G. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/386527 · Cited by 111 · see citing works

Rivastigmine for vascular cognitive impairment

Birks, J., McGuinness, B., & Craig, D. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004744.pub3 · Cited by 110 · see citing works

Efficacy and Safety of Galantamine in Patients with Dementia with Lewy Bodies: A 24-Week Open-Label Study

Edwards, K. R., Royall, D. R., Hershey, L. A., Lichter, D. G., Hake, A. M., Farlow, M. R., Pasquier, F., & Johnson, S. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000101512 · Cited by 109 · see citing works

The combination of berberine and irradiation enhances anti‐cancer effects via activation of p38 MAPK pathway and ROS generation in human hepatoma cells

Hur, J., Hyun, M., Lim, S., et al. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22198 · Cited by 108 · see citing works

Curcumin Inhibits Aβ-Induced Microglial Inflammatory Responses In Vitro: Involvement of ERK1/2 and P38 Signaling Pathways

Shi, X., Zheng, Z., Li, J., Xiao, Z., Qi, W., Zhang, A., Wu, Q., & Fang, Y. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.03.045 · Cited by 108 · see citing works

Antiinflammatory activity of glucomoringin isothiocyanate in a mouse model of experimental autoimmune encephalomyelitis

Galuppo, M., Giacoppo, S., Nicola, G. R. D., Iori, R., Navarra, M., Lombardo, G. E., Bramanti, P., & Mazzon, E. (2014) · Fitoterapia · doi:10.1016/j.fitote.2014.03.018 · Cited by 105 · see citing works

Exploiting plant alkaloids

Schläger, S., & Dräger, B. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.12.003 · Cited by 105 · see citing works

Repeated nicotine exposure in rats: Effects on memory function, cholinergic markers and nerve growth factor

Hernandez, C. M., & Terry, A. V. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.10.006 · Cited by 104 · see citing works

Histone Acetyltransferase p300 Mediates Histone Acetylation of PS1 and BACE1 in a Cellular Model of Alzheimer's Disease

Lu, X., Deng, Y., Yu, D., Cao, H., Wang, L., Liu, L., Yu, C., Zhang, Y., Guo, X., & Yu, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103067 · Cited by 104 · see citing works

Alteration of brain monoamines & EEG wave pattern in rat model of Alzheimer's disease & protection by Moringa oleifera.

Ganguly, R., & Guha, D. (2008) · PubMed · Cited by 104 · see citing works

Natural polyphenols binding to amyloid: A broad class of compounds to treat different human amyloid diseases

Ndam, V. N., Schluesener, J. K., Moundipa, P. F., & Schluesener, H. J. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400290 · Cited by 103 · see citing works

Cardiovascular Effects of Drugs Used to Treat Alzheimer’s Disease

Howes, L. G. (2014) · Drug Safety · doi:10.1007/s40264-014-0161-z · Cited by 102 · see citing works

Curcumin as a Therapeutic Agent in Dementia: A Mini Systematic Review of Human Studies

Brondino, N., Re, S., Boldrini, A., Cuccomarino, A. F., Lanati, N., Barale, F., & Politi, P. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/174282 · Cited by 99 · see citing works

A critical review of cholinesterase inhibitors as a treatment modality in Alzheimer's disease

Schneider, L. S. S. (2000) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2000.2.2/lschneider · Cited by 99 · see citing works

Galantamine inhibits β-amyloid aggregation and cytotoxicity

Matharu, B., Gibson, G. L., Parsons, R. B., Huckerby, T. N., Moore, S. A., Cooper, L. J., Millichamp, R., Allsop, D., & Austen, B. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.01.024 · Cited by 98 · see citing works

Attenuation of β -Amyloid-Induced Oxidative Cell Death by Sulforaphane via Activation of NF-E2-Related Factor 2

Lee, C., Park, G. H., Lee, S., & Jang, J. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/313510 · Cited by 97 · see citing works

Mechanisms of Action of Phytochemicals from Medicinal Herbs in the Treatment of Alzheimerʼs Disease

Kim, M. S., Kim, S., & Yang, W. M. (2014) · Planta Medica · doi:10.1055/s-0034-1383038 · Cited by 96 · see citing works

CB1 receptor selective activation inhibits β-amyloid-induced iNOS protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons

Esposito, G., Filippis, D. D., Steardo, L., Scuderi, C., Savani, C., Cuomo, V., & Iuvone, T. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.06.012 · Cited by 95 · see citing works

Cannabinoids for the treatment of dementia

Krishnan, S., Cairns, R., & Howard, R. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007204.pub2 · Cited by 91 · see citing works

Positive modulators of the α7 nicotinic receptor against neuroinflammation and cognitive impairment in Alzheimer's disease

Echeverrı́a, V., Iarkov, A., & Aliev, G. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.01.002 · Cited by 91 · see citing works

Neuroprotective Effects of Sulforaphane on Cholinergic Neurons in Mice with Alzheimer’s Disease-Like Lesions

Zhang, R., Zhang, J., Fang, L., Li, X., Zhao, Y., Shi, W., & An, L. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150814396 · Cited by 88 · see citing works

Resveratrol inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in β-amyloid-treated C6 glioma cells

Kim, Y., Lim, S., Rhee, S., Park, K., Kim, C., Choi, B., Lee, S. J., Park, Y., & Choi, Y. H. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.6.1069 · Cited by 88 · see citing works

The Antioxidant Properties of Organosulfur Compounds (Sulforaphane)

de Figueiredo, S., Binda, N. S., Nogueira‐Machado, J. A., Filho, S. A. V., & Caligiorne, R. B. (2015) · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · doi:10.2174/1872214809666150505164138 · Cited by 88 · see citing works

Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia.

Ma, X., Sun, Z., Liu, Y., Jia, Y., Zhang, B., & Zhang, J. (2013) · PubMed Central · doi:10.3969/j.issn.1673-5374.2013.22.004 · Cited by 87 · see citing works

Neuroprotective activities of curcumin and quercetin with potential relevance to mitochondrial dysfunction induced by oxaliplatin

Waseem, M., & Parvez, S. (2015) · PROTOPLASMA · doi:10.1007/s00709-015-0821-6 · Cited by 86 · see citing works

Protective effects of huperzine A on β-amyloid25–35 induced oxidative injury in rat pheochromocytoma cells

Xiao, X., Wang, R., Han, Y., & Tang, X. C. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01088-0 · Cited by 85 · see citing works

Effects of donepezil, an acetylcholinesterase inhibitor, on neurogenesis in a rat model of vascular dementia

Kwon, K. J., Kim, M. K., Lee, E. J., et al. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.09.021 · Cited by 82 · see citing works

Sulforaphane alleviates scopolamine-induced memory impairment in mice

Lee, S., Kim, J., Seo, S. G., Choi, B., Han, J., Lee, K. W., & Kim, J. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.05.003 · Cited by 82 · see citing works

Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson's disease

Kwon, I. H., Choi, H. S., Shin, K. S., Lee, B. K., Lee, C. K., Hwang, B. Y., Lim, S. C., & Lee, M. K. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.09.038 · Cited by 81 · see citing works

Huperzine A protects SHSY5Y neuroblastoma cells against oxidative stress damage via nerve growth factor production

Tang, L., Wang, R. T., & Tang, X.-C. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.06.026 · Cited by 79 · see citing works

Protection against amyloid beta cytotoxicity by sulforaphane: Role of the proteasome

Park, H.-M., Kim, J., & Kwak, M. (2009) · Archives of Pharmacal Research · doi:10.1007/s12272-009-1124-2 · Cited by 79 · see citing works

Sirtuins in cognitive ageing and Alzheimer's disease

Braidy, N., Jayasena, T., Poljak, A., & Sachdev, P. S. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32835112c1 · Cited by 79 · see citing works

Cannabinoids: new promising agents in the treatment of neurological diseases.

Giacoppo, S., Mandolino, G., Galuppo, M., Bramanti, P., & Mazzon, E. (2014) · Molecules · doi:10.3390/molecules191118781 · Cited by 79 · see citing works

Current and Emerging Pharmacological Treatment Options for Dementia

Ringman, J. M., & Cummings, J. L. (2006) · Behavioural Neurology · doi:10.1155/2006/315386 · Cited by 76 · see citing works

Huperzine A promotes hippocampal neurogenesis in vitro and in vivo

Ma, T., Gong, K., Yan, Y., Zhang, L., Tang, P., Zhang, X., & Gong, Y. (2013) · Brain Research · doi:10.1016/j.brainres.2013.02.026 · Cited by 74 · see citing works

Morphine Protects against Intracellular Amyloid Toxicity by Inducing Estradiol Release and Upregulation of Hsp70

Cui, J., Wang, Y.-F., Dong, Q., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3915-11.2011 · Cited by 74 · see citing works

Sulforaphane Ameliorates Neurobehavioral Deficits and Protects the Brain From Amyloid β Deposits and Peroxidation in Mice With Alzheimer-Like Lesions

Zhang, R., Miao, Q.-W., Zhu, C., Zhao, Y., Liu, L., Yang, J., & An, L. (2014) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317514542645 · Cited by 74 · see citing works

Chronic caffeine treatment reverses memory impairment and the expression of brain BNDF and TrkB in the PS1/APP double transgenic mouse model of Alzheimer’s disease

Han, K., Jia, N., Ji, L., Li, Y., & Min, L. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1601 · Cited by 71 · see citing works

Curcumin derivative with the substitution at C-4 position, but not curcumin, is effective against amyloid pathology in APP/PS1 mice

Yanagisawa, D., Ibrahim, N. F., Taguchi, H., Morikawa, S., Hirao, K., Shirai, N., Sogabe, T., & Tooyama, I. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.041 · Cited by 71 · see citing works

Huperzine A enhances the level of secretory amyloid precursor protein and protein kinase C-α in intracerebroventricular β-amyloid-(1–40) infused rats and human embryonic kidney 293 Swedish mutant cells

Zhang, H., Yan, H., & Tang, X. C. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.01.055 · Cited by 70 · see citing works

Current Practices in the Treatment of Alzheimer Disease: Where is the Evidence After the Phase III Trials?

Ehret, M. J., & Chamberlin, K. W. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.05.510 · Cited by 70 · see citing works

Berberine induces heme oxygenase-1 up-regulation through phosphatidylinositol 3-kinase/AKT and NF-E2-related factor-2 signaling pathway in astrocytes

Chen, J., Huang, S.-M., Tan, T., et al. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.10.019 · Cited by 69 · see citing works

Caffeine Intake from Coffee or Tea and Cognitive Disorders: A Meta-Analysis of Observational Studies

Kim, Y. S., Kwak, S. M., & Myung, S. (2015) · Neuroepidemiology · doi:10.1159/000371710 · Cited by 68 · see citing works

Huperzine a attenuates mitochondrial dysfunction in β‐amyloid‐treated PC12 cells by reducing oxygen free radicals accumulation and improving mitochondrial energy metabolism

Gao, X., & Tang, X. C. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20791 · Cited by 68 · see citing works

Up-regulation of cytochrome P450 and phase II enzyme systems in rat precision-cut rat lung slices by the intact glucosinolates, glucoraphanin and glucoerucin

Razis, A. F. A., Bagatta, M., Nicola, G. R. D., et al. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.06.015 · Cited by 66 · see citing works

Antioxidant Activity of Galantamine and Some of its Derivatives

Tsvetkova, D. D., Obreshkova, D. P., Zheleva‐Dimitrova, D., & Saso, L. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990148 · Cited by 65 · see citing works

Sulforaphane Ameliorates Okadaic Acid-Induced Memory Impairment in Rats by Activating the Nrf2/HO-1 Antioxidant Pathway

Dwivedi, S., Rajasekar, N., Hanif, K., Nath, C., & Shukla, R. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9451-4 · Cited by 65 · see citing works

Galantamine protects against oxidative stress induced by amyloid‐beta peptide in cortical neurons

Melo, J. B., Sousa, C., Garção, P., Oliveira, C. R., & Agostinho, P. M. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06612.x · Cited by 63 · see citing works

4(α-l-Rhamnosyloxy)-benzyl isothiocyanate, a bioactive phytochemical that attenuates secondary damage in an experimental model of spinal cord injury

Giacoppo, S., Galuppo, M., Nicola, G. R. D., Iori, R., Bramanti, P., & Mazzon, E. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.11.022 · Cited by 62 · see citing works

Potential role of the combination of galantamine and memantine to improve cognition in schizophrenia

Koola, M. M., Buchanan, R. W., Pillai, A., Aitchison, K. J., Weinberger, D. R., Aaronson, S. T., & Dickerson, F. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.04.037 · Cited by 62 · see citing works

Combination therapies: The next logical Step for the treatment of synucleinopathies?

Valera, E., & Masliah, E. (2015) · Movement Disorders · doi:10.1002/mds.26428 · Cited by 62 · see citing works

Comprehensive treatment of dementia with Lewy bodies

Boot, B. P. (2015) · Alzheimer s Research & Therapy · doi:10.1186/s13195-015-0128-z · Cited by 60 · see citing works

Anticholinesterase effects of huperzine A, E2020, and tacrine in rats.

Wang, H., & Tang, X. C. (1998) · PubMed · Cited by 59 · see citing works

Treatment with Huperzine A Improves Cognition in Vascular Dementia Patients

Xu, Z., Liang, X., Juan-Wu, Zhang, Y.-F., Zhu, C., & Jiang, X. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9258-5 · Cited by 58 · see citing works

Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation

Sharifi-Rad, J., Rapposelli, S., Sestito, S., Herrera-Bravo, J., Arancibia-Diaz, A., Salazar, L. A., Yeskaliyeva, B., Beyatli, A., Leyva-Gómez, G., González-Contreras, C., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091515 · Cited by 125 · see citing works

DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION

Mustafa, N. H., Kelesbayev, D., & Alibekova, Z. D. (2018) · The Journal of Economic Research & Business Administration · doi:10.26577/be-2018-2-2141

Susquehanna Chorale Spring Concert "Roots and Wings"

Hawkins, D. (2017)

Genentech taps Affimed’s antibodies

Cross, R. (2018) · C&EN Global Enterprise · doi:10.1021/cen-09635-buscon15

KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK

Sari, D. (2023) · Jurnal Komplikasi Anestesi · doi:10.22146/jka.v5i1.7322

Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria

Dib, A., Puig, L. B., Salvadori, D., et al. (1988) · Arquivos Brasileiros de Cardiologia